Regencell Bioscience Holdings Ltd (RGC)
5.10
-0.60
(-10.53%)
USD |
NASDAQ |
Apr 24, 16:00
5.70
+0.60
(+11.76%)
After-Hours: 20:00
Regencell Bioscience Holdings Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 5.516 |
| April 23, 2024 | 6.166 |
| April 22, 2024 | 6.966 |
| April 19, 2024 | 6.003 |
| April 18, 2024 | 5.646 |
| April 17, 2024 | 5.124 |
| April 16, 2024 | 4.013 |
| April 15, 2024 | 4.013 |
| April 12, 2024 | 4.121 |
| April 11, 2024 | 4.110 |
| April 10, 2024 | 3.970 |
| April 09, 2024 | 4.100 |
| April 08, 2024 | 4.218 |
| April 05, 2024 | 4.218 |
| April 04, 2024 | 4.024 |
| April 03, 2024 | 4.181 |
| April 02, 2024 | 4.327 |
| April 01, 2024 | 4.218 |
| March 28, 2024 | 4.868 |
| March 27, 2024 | 3.753 |
| March 26, 2024 | 3.732 |
| March 25, 2024 | 4.002 |
| March 22, 2024 | 3.786 |
| March 21, 2024 | 4.154 |
| March 20, 2024 | 4.316 |
| Date | Value |
|---|---|
| March 19, 2024 | 4.381 |
| March 18, 2024 | 4.868 |
| March 15, 2024 | 5.003 |
| March 14, 2024 | 5.289 |
| March 13, 2024 | 6.068 |
| March 12, 2024 | 4.868 |
| March 11, 2024 | 4.868 |
| March 08, 2024 | 4.868 |
| March 07, 2024 | 5.387 |
| March 06, 2024 | 6.241 |
| March 05, 2024 | 6.241 |
| March 04, 2024 | 6.49 |
| March 01, 2024 | 7.074 |
| February 29, 2024 | 7.301 |
| February 28, 2024 | 7.637 |
| February 27, 2024 | 7.864 |
| February 26, 2024 | 7.734 |
| February 23, 2024 | 8.188 |
| February 22, 2024 | 8.188 |
| February 21, 2024 | 8.426 |
| February 20, 2024 | 8.426 |
| February 16, 2024 | 8.653 |
| February 15, 2024 | 8.113 |
| February 14, 2024 | 8.069 |
| February 13, 2024 | 8.069 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.732
Minimum
Mar 26 2024
31.11
Maximum
Jul 11 2022
19.04
Average
21.00
Median
Oct 21 2022
Price to Book Value Benchmarks
| Global Pharmatech Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.706 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6402 |
| Theriva Biologics Inc | 0.1902 |
Price to Book Value Related Metrics
| Price | 5.10 |
| Market Cap | 66.37M |